Phil Mitchell

Cooley advised Blue Owl Capital (NYSE: OWL), an asset manager redefining alternatives, on an up to $262.5 million term loan facility for ITM Isotope Technologies Munich SE, a radiopharmaceutical biotech company dedicated to providing a new generation of radiopharmaceutical therapeutics and diagnostics for hard-to-treat tumors.

Cooley advised Oberland Capital, a private investment firm committed to funding innovation across the global healthcare industry, on its agreement to invest up to $600 million in Biohaven (NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases.

Cooley advised MongoDB (Nasdaq: MDB), a leading database for modern applications, on its acquisition of Voyage AI, a pioneer in state-of-the-art embedding and reranking models that power next-generation artificial intelligence applications.

Cooley advised Redacted RnD, a company founded by Brooklyn Earick with a focus on technology, sports, and media and entertainment, on its acquisition of the Maserati Formula E team.

Cooley advised the underwriters of Aardvark Therapeutics, a phase 3 biotech company developing novel small-molecule therapies for metabolic diseases, in connection with Aardvark’s $94.2 million initial public offering (IPO).